Vaccine Safety

Abstract

We are now near the end of the second year of the COVID-19 pandemic, and it has been a year since the first International System Safety Society (ISSS) Conference coronavirus presentation. This past year has seen the development and distribution of several vaccines, as predicted in the previous publication about the pandemic. These new weapons against disease will save millions of lives all over the globe in the next few years — and they were developed faster than any vaccine in medical history. Yet these same vaccines have been the victim of numerous allegations from the start. In fact, their strongest virtue — the speed with which they were developed and distributed — is seen by their critics as a fault, possibly resulting in an unsafe or insufficiently tested product. Is there any truth to these claims? How do these vaccines work? And how are they made? Vaccine Safety.
 In order to establish an orderly, technically accurate, objective, and comprehensive record of the events of these times that is accessible to the general public and of some use to posterity, this second publication has been prepared. It is also hoped that this report will mitigate some of the concerns that people have about vaccine safety.

Delta Variant

“…Starting in this section, it would be best for the reader to examine the first two coronavirus papers in this series (Zito. 2020b(Zito. , 2021.…”

“…These side chains can interact with one another through disulfide bonds (from a sulfur atom in one subunit to a sulfur atom in its neighbor subunit), as well as hydrogen bonding, Van der Walls forces, and other types of non-permanent interactions. Recall from "Vaccine Safety" (Zito, 2021) that hemoglobin has four such subunits.…”

“…Folding occurs for the same reasons (and involves the same types of bonds) that make subunits stick together. 2 Sometimes, however, a mutation occurs in the primary amino acid sequence, for reasons that will be explained in the next section. When that happens, one letter (label) can change to another.…”

“…Consequently, for vaccines other than flu, the one-month rule should be observed. Furthermore, as discussed in "Vaccine Safety" (Zito, 2021), a time may come in the near future when an mRNA flu vaccination will be combined with an mRNA coronavirus vaccine. When that happens, people who have successfully modified their vaccination schedule will be in an ideal position to replace the vaccinations for the two diseases with a single "combo" shot.…”

“…If, for example, the amino acid preceding 157 and 158 were serine (coded by UCA), and if a point mutation changed the middle C to an A, then the UCA codon would be changed to the UAA STOP codon. In that case, if amino acids 157 and 158 were at the end of a protein chain (for S they are not), they would simply be clipped off the end of the protein chain in the new (d) version of the S-protein during cellular manufacture (Zito, 2021). It is for all these reasons that the probability for a significant mutation in the second paper of this series (Zito, 2021) was set at ~ 2.5 x 10 -8 per year per infected person (~ the product of the probabilities for two point mutations).…”